Clinical Application of Microcatheter in Transcatheter Arterial Chemoembolization Therapy for Primary Liver Cancer

刘嵘,王建华,周康荣,颜志平,程洁敏,刘清欣,钱晟,龚高全

DOI: https://doi.org/10.3969/j.issn.1001-9324.2002.03.016

2002-01-01

Abstract:Objective To evaluate 3.0F microcatheter in clinical transcatheter arterial chemoembolization therapy (TACE) for primary liver cancer, and to discuss the manipulative technique and indications of using microcatheter. Materials and Methods Using emulsion of Lipiodol with antineoplastic medicine as embolic agents, TACE, using a 3.0F SP microcatheter, was performed in 32 patients of primary liver cancer. The reason to use a microcatheter in this group was as follows. (1) The blood supply of the tumor was from extrahepatic collaterals (n=9). (2) The tumor feeding artery was so small that super selective catheterization was needed (n=16). (3) Anatomic variations of celiac and common hepatic artery (n=6). (4) hepatic artery spasm (n=1).Results The microcatheter was used 42 times in 32 patients. The catheterization was successful in 39 procedures (92.9%) and failure in 3. After therapy, serum AFP reduction over 50% was noted in 27 patients (84.4%), while tumor size reduced over 50% in 8 (25%) and less than 50% in 16 (50%). Successful internal sub segmental hepatectomy was carried out in 2 patients. No serious complication occurred in all patients.Conclusion The manipulation of microcatheter is simple and easy, with a high successful rate. The microcatheter technique has great value in TACE therapy for primary liver cancer, especially for patients with small, severely narrowed, tortuous or easily spastic tumor feeding arteries.